These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 7793997

  • 41. Buffered hydrochloric acid: a modern method of treating metabolic alkalosis.
    Finkle D, Dean RE.
    Am Surg; 1981 Mar; 47(3):103-6. PubMed ID: 6782923
    [Abstract] [Full Text] [Related]

  • 42. Effect of Personalized Nutrition Combined with Acceptance and Commitment Therapy on Psychological Resilience, Quality of Life and Side Effects of Chemotherapy in Patients with Advanced Gastric Cancer.
    Hu H, Li H, Xu H, Liu J, Qi Y.
    Br J Hosp Med (Lond); 2024 Sep 30; 85(9):1-16. PubMed ID: 39347679
    [Abstract] [Full Text] [Related]

  • 43. [Clinical study of amino acid imbalance as an adjunct to cancer therapy].
    Goseki N, Onodera T, Mori S, Menjo M.
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct 20; 17(7):1908-16. PubMed ID: 6819332
    [No Abstract] [Full Text] [Related]

  • 44. [Effect of parenteral feeding preparations on plasma amino acids of oncology patients who have undergone surgery on the gastrointestinal tract].
    Vasil'ev PS, Klimanskiĭ VA, Suzdaleva VV, Golovastova GI, Zagrekov IA.
    Probl Gematol Pereliv Krovi; 1982 Aug 20; 27(8):28-32. PubMed ID: 6813843
    [No Abstract] [Full Text] [Related]

  • 45. [Studies on postoperative magnesium metabolism of patients with gastric cancer. Especially in relation to protein metabolism].
    Yoshimoto S.
    Sapporo Igaku Zasshi; 1970 Aug 20; 37(4):133-47. PubMed ID: 5530716
    [No Abstract] [Full Text] [Related]

  • 46. [Application of quality of life scale in evaluating the efficacy of gastric cancer treatment].
    Zheng J, Zheng J, Zheng PY.
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar 20; 6(3):304-10. PubMed ID: 18334154
    [No Abstract] [Full Text] [Related]

  • 47. Tumor biology and quality of life in patients with gastric cancer.
    Rau E.
    Cancer Treat Res; 1991 Mar 20; 55():325-38. PubMed ID: 1681864
    [No Abstract] [Full Text] [Related]

  • 48. Metabolic interaction between amino acid deprivation and cisplatin synergistically reduces phosphoribosyl-pyrophosphate and augments cisplatin cytotoxicity.
    Wahwah N, Dhar D, Chen H, Zhuang S, Chan A, Casteel DE, Kalyanaraman H, Pilz RB, Boss GR.
    Sci Rep; 2020 Nov 16; 10(1):19907. PubMed ID: 33199755
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C].
    Kurihara M, Kosaki G, Taguchi T, Akazawa S, Sasaki T, Takahashi H, Onodera T, Endo M, Nakagawara G, Sano K.
    Gan To Kagaku Ryoho; 1995 Jun 16; 22(7):911-23. PubMed ID: 7793997
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
    Goseki N, Maruyama M, Nagai K, Kando F, Endo M, Shimoju K, Wada Y.
    Gan To Kagaku Ryoho; 1995 Jul 16; 22(8):1028-35. PubMed ID: 7611753
    [Abstract] [Full Text] [Related]

  • 55. [Application of quality of life scale in evaluating the efficacy of gastric cancer treatment].
    Zheng J, Zheng J, Zheng PY.
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar 16; 6(3):304-10. PubMed ID: 18334154
    [No Abstract] [Full Text] [Related]

  • 56. [Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C].
    Kurihara M, Kosaki G, Taguchi T, Akazawa S, Sasaki T, Takahashi H, Onodera T, Endo M, Nakagawara G, Sano K.
    Gan To Kagaku Ryoho; 1995 Jun 16; 22(7):911-23. PubMed ID: 7793997
    [Abstract] [Full Text] [Related]

  • 57. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
    Kitamura S, Ohtani T, Kurihara M, Kosaki G, Akazawa S, Sasaki T, Takahashi H, Nakano S, Tokunaga K.
    Gan To Kagaku Ryoho; 1995 May 16; 22(6):765-75. PubMed ID: 7755384
    [Abstract] [Full Text] [Related]

  • 58. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)].
    Taguchi T, Kosaki G, Onodera T, Endo M, Nakagawara G, Sano K, Kaibara N, Kakegawa T, Nakano S, Kurihara M.
    Gan To Kagaku Ryoho; 1995 May 16; 22(6):753-64. PubMed ID: 7755383
    [Abstract] [Full Text] [Related]

  • 59. [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
    Goseki N, Maruyama M, Nagai K, Kando F, Endo M, Shimoju K, Wada Y.
    Gan To Kagaku Ryoho; 1995 Jul 16; 22(8):1028-35. PubMed ID: 7611753
    [Abstract] [Full Text] [Related]

  • 60. [Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group].
    Sugihara K, Auther C, Mori S, Nishihira T, Matsumoto T, Kawachi S, Ishikawa M, Takahashi M, Nakajima T, Kosaki G.
    Gan To Kagaku Ryoho; 1990 Dec 16; 17(12):2405-13. PubMed ID: 2124434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.